CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.
CompagOs has raised $117K in total funding. The most recent round was Convertible Note. The last funding was announced in September 2024.
CompagOs's investors include Venture Kick, Kickfund.
CompagOs is headquartered in Hünenberg, Switzerland.
CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.
CompagOs is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CompagOs — Funding & Investors." VCBacked, September 2, 2024, https://www.vcbacked.co/company/compagos. Accessed November 11, 2026.
VCBacked. (2024). CompagOs — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/compagos
{{cite web |title=CompagOs — Funding & Investors |url=https://www.vcbacked.co/company/compagos |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CompagOs? Request a listing update